Roche Holding AG

Equities

ROG

CH0012032048

Market Closed - Swiss Exchange Other stock markets 11:30:00 2026-01-19 am EST			5-day change	1st Jan Change
346.80 ^CHF	-0.60%		+1.26%	+5.67%

Jan. 18	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
Jan. 16	Goldman Sachs Upgrades Roche to Neutral, Boosts PT	MT

Transcript : Roche Holding AG - Shareholder/Analyst Call

Published on 12/11/2025 at 03:05 pm EST - Modified on 12/11/2025 at 09:22 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning. Welcome to Roche Virtual Oncology SABCS Investor Event. My name is Henrik, and I'm the technical operator for today's call. Kindly note

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Roche Holding AG

Jan. 18	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
Jan. 16	Goldman Sachs Upgrades Roche to Neutral, Boosts PT	MT
Jan. 16	Bayer Receives EU Approval for High-Dose Eylea in Another Indication	DP
Jan. 16	ROCHE HOLDINGS AG : UBS gives a Buy rating	ZD
Jan. 16	ROCHE HOLDINGS AG : Gets a Neutral rating from Deutsche Bank	ZD
Jan. 16	ROCHE HOLDINGS AG : Goldman Sachs from Sell to Neutral	ZD
Jan. 15	Espiria Hållbar Framtid Rises 0.4 Percent in December — Increased Holdings in Epiroc and Afry	FW
Jan. 15	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
Jan. 15	ROCHE HOLDINGS AG : Gets a Buy rating from Barclays	ZD
Jan. 15	BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China	RE
Jan. 13	BGI, Roche roll out diagnostic tests for Alzheimer's in China	RE
Jan. 13	Roche Pharma CEO on Company's Obesity Assets	MT
Jan. 13	The CPI That Changed Almost Nothing
Jan. 13	Ro announces research collaboration with Amgen to evaluate real-world GLP-1 coverage	RE
Jan. 13	AlphaValue/Baader Europe Downgrades Roche to Reduce, Lifts PT	MT
Jan. 13	Global drugmakers rush to boost US presence as tariff threat looms	RE
Jan. 13	Davos begins new era grappling with global order shaken by Trump	RE
Jan. 13	ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating	ZD
Jan. 12	AbbVie to cut drug prices, pledges $100 billion for research	RE
Jan. 12	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI
Jan. 12	SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs	RE
Jan. 12	Lancelot Stabil Up 0.3 Percent in December – Increased Exposure to Government Bonds	FW
Jan. 09	ROCHE HOLDINGS AG : Bernstein reiterates its Buy rating	ZD
Jan. 08	Medilink says it has signed an additional exclusive licensing agreement with Roche	RE
Jan. 08	ROCHE HOLDINGS AG : Berenberg remains Neutral	ZD